These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 4582360)

  • 1. Phenothiazine effects in good premorbid schizophrenics divided into paranoid-nonparanoid status.
    Judd LL; Goldstein MJ; Rodnick EH; Jackson NL
    Arch Gen Psychiatry; 1973 Aug; 29(2):207-21. PubMed ID: 4582360
    [No Abstract]   [Full Text] [Related]  

  • 2. Piperacetazine in ambulatory chronic schizophrenic patients.
    Rada RT; Donlon PT
    Curr Ther Res Clin Exp; 1974 Feb; 16(2):124-9. PubMed ID: 4156665
    [No Abstract]   [Full Text] [Related]  

  • 3. Premorbid adjustment, phenothiazine treatment, and remission in acute schizophrenics.
    Evans JR; Rodnick EH; Goldstein MJ; Judd LL
    Arch Gen Psychiatry; 1972 Oct; 27(4):486-90. PubMed ID: 4342117
    [No Abstract]   [Full Text] [Related]  

  • 4. Prediction of response to phenothiazines in schizophrenia. A crossvalidation study.
    Goldberg SC; Frosch WA; Drossman AK; Schooler NR; Johnson GF
    Arch Gen Psychiatry; 1972 Apr; 26(4):367-73. PubMed ID: 4552130
    [No Abstract]   [Full Text] [Related]  

  • 5. Penfluridol (R 16341) as a maintenance therapy in chronic psychotic patients: a double-blind clinical evaluation.
    Roelofs GA
    Acta Psychiatr Scand; 1974; 50(2):219-24. PubMed ID: 4604881
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug effects on auditory attention in paranoid and nonparanoid schizophrenics.
    Rappaport M; Hopkins HK
    J Nerv Ment Dis; 1969 Jun; 148(6):597-605. PubMed ID: 5772724
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical differences among phenothiazines in schizophrenics. Introduction: specific indications for antipsychotics: elusive end of the rainbow.
    Hollister LE
    Adv Biochem Psychopharmacol; 1974; 9(0):667-73. PubMed ID: 4151921
    [No Abstract]   [Full Text] [Related]  

  • 8. Specific indications for different classes of phenothiazines.
    Hollister LE; Overall JE; Kimbell I; Pokorny A
    Arch Gen Psychiatry; 1974 Jan; 30(1):94-9. PubMed ID: 4148660
    [No Abstract]   [Full Text] [Related]  

  • 9. Phenothiazine effects on auditory signal detection in paranoid and nonparanoid schizophrenics.
    Rappaport M; Silverman J; Hopkins HK; Hall K
    Science; 1971 Nov; 174(4010):723-5. PubMed ID: 5123424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pipothiazine (piportil) in the treatment of various forms of schizophrenia].
    Matkowski K; Sep-Kowalikowa B
    Psychiatr Pol; 1979; 13(4):421-3. PubMed ID: 42095
    [No Abstract]   [Full Text] [Related]  

  • 11. Psychophysiological and behavioral effects of phenothiazine administration in acute schizophrenics as a function of premorbid status.
    LaPolla A; Goldstein MJ; Judd LL; Rodnick EH
    J Psychiatr Res; 1969 May; 6(4):271-87. PubMed ID: 4892691
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparative study of butaperazine, chlorpromazine and placebo in chronic schizophrenics.
    Keskiner A; Itil TM; Todt N
    Psychosomatics; 1970; 11(2):120-6. PubMed ID: 4394278
    [No Abstract]   [Full Text] [Related]  

  • 13. Performance tests in a study of phenothiazines in schizophrenia: caveats and conclusions.
    Schooler NR; Goldberg SC
    Psychopharmacologia; 1972; 24(1):81-98. PubMed ID: 5062969
    [No Abstract]   [Full Text] [Related]  

  • 14. Paranoid and nonparanoid schizophrenic processing of facially displayed affect.
    Kline JS; Smith JE; Ellis HC
    J Psychiatr Res; 1992 Jul; 26(3):169-82. PubMed ID: 1432844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pimozide and piportil in the treatment of chronic schizophrenia (preliminary communication)].
    Masiak M; Majczak A; Hascewicz-Rzecka M; Kowalczyk A
    Psychiatr Pol; 1976; 10(6):655-60. PubMed ID: 13443
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of loxapine in the treatment of paranoid schizophrenia.
    Bishop MP; Simpson GM; Dunnett CW; Kiltie H
    Psychopharmacology (Berl); 1977 Jan; 51(2):107-15. PubMed ID: 14350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of piperacetazine (Quide) injection in acute schizophrenics.
    Kiev A; Güclü B; Kulkarni AS
    Curr Ther Res Clin Exp; 1972 Jul; 14(7):376-80. PubMed ID: 4625517
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of phenothiazines on reaction time in schizophrenics.
    Held JM; Cromwell RL; Frank ET; Fann WE
    J Psychiatr Res; 1970 Feb; 7(3):209-13. PubMed ID: 5440861
    [No Abstract]   [Full Text] [Related]  

  • 19. Auditory signal detection in paranoid and nonparanoid schizophrenics.
    Rappaport M; Hopkins HK; Hall K
    Arch Gen Psychiatry; 1972 Dec; 27(6):747-52. PubMed ID: 4404700
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of fluspirilene and trifluoperazine in the treatment of acute schizophrenic psychosis.
    Bankier RG
    J Clin Pharmacol New Drugs; 1973 Jan; 13(1):44-7. PubMed ID: 4566123
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.